Abstract
Personalized medicine, also known as precision medicine, refers to a medical model of providing the best treatment plan for a patient according to his or her personal genomic information. The research and practice of personalized medicine have become a hot topic in current medical research, and predicting the response of cell lines to specific drugs is one of the core problems. Using computer algorithms to predict the responses of cell lines to drugs based on huge amounts of existing omics information is currently one focus of bioinformatics. A variety of predictive methods have been proposed. The paper introduces the baseline analysis data, surveys some classical prediction methods and models, and details on the application of matrix decomposition, heterozygous network and deep learning at the drug response prediction. At last, some existing problems and future development trend and prospects are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roses, A.D.: Pharmacogenetics in drug discovery and development: a translational per spective. Nat. Rev. Drug Discov. 7(10), 807–817 (2008)
Dugger, S.A., Platt, A., Goldstein, D.B.: Drug development in the era of precision medicine. Nat. Rev. Drug Discov. 17(3), 183–196 (2018)
Bo, H., Yongqian, S., Ping, L., et al.: Precision medicine for oncology: concepts, techniques, and prospects. Tech. Rev. 33(15), 14–21 (2015)
Sebaugh, J.L.: Guidelines for accurate EC50/IC50 estimation. Pharm. Stat. 10(2), 128–134 (2011)
Neubig, R.R., Spedding, M., Kenakin, T., et al.: International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharm. Rev. 55(4), 597–606 (2003)
Liu, D.Y., Ye, K.Q., Wang, H.Z., et al.: Research progress in the prediction of antitumor drug sensitivity based on functional test. Electron. J. Trans. Med. 004(001), 1–6 (2017)
Alley, M.C., Scudiero, D.A., Monks, A., et al.: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Can. Res. 48(3), 589–601 (1988)
Shoemaker, R.H.: The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6(10), 813–823 (2006)
Ali, M., Aittokallio, T.: Machine learning and feature selection for drug response prediction in precision oncology applications. Biophys. Rev. 11(1), 31–39 (2018). https://doi.org/10.1007/s12551-018-0446-z
DeNiz, C., Rahman, R., Zhao, X., et al.: Algorithms for drug sensitivity prediction. Algorithms 9(4), 77 (2016)
Huang, S., Chaudhary, K., Garmire, L.X.: More is better: recent progress in multi-omics data integration methods. Front. Genet. 8, 84 (2017)
Güvenç, P.B., Mamitsuka, H., Kaski, S.: Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches. Brief. Bioinform. 22(1), 346–359 (2021)
Azuaje, F.: Computational models for predicting drug responses in cancer research. Brief. Bioinform. 18(5), 820–829 (2017)
Wang, L., Li, X., Zhang, L., et al.: Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization. BMC Cancer 17(1), 1–12 (2017)
Emdadi, A., Eslahchi, C.: Dsplmf: a method for cancer drug sensitivity prediction using a novel regularization approach in logistic matrix factorization. Front. Genet. 11, 75 (2020)
Guan, N.N., Zhao, Y., Wang, C.C., et al.: Anticancer drug response prediction in cell lines using weighted graph regularized matrix factorization. Molecular Therapy-Nucleic Acids 17, 164–174 (2019)
Wang, S., Li, J.: Modular within and between score for drug response prediction in cancer cell lines. Mol. Omics 16(1), 31–38 (2020)
Zhang, F., Wang, M., Xi, J., et al.: A novel heterogeneous network-based method for drug response prediction in cancer cell lines. Sci. Rep. 8(1), 1–9 (2018)
Yang, J., Li, A., Li, Y., et al.: A novel approach for drug response prediction in cancer cell lines via network representation learning. Bioinformatics 35(9), 1527–1535 (2019)
Sakellaropoulos, T., Vougas, K., Narang, S., et al.: A deep learning framework for predicting response to therapy in cancer. Cell Rep. 29(11), 3367–3373 (2019)
Sharifi-Noghabi, H., Zolotareva, O., Collins, C.C., et al.: MOLI: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics 35(14), 501–509 (2019)
Choi, J., Park, S., Ahn, J.: RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance. Sci. Rep. 7(10), 1–11 (2020)
Liu, P., Li, H., Li, S., et al.: Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network. BMC Bioinform. 20(1), 1–14 (2019)
Chiu, Y.C., Chen, H.I.H., Zhang, T., et al.: Predicting drug response of tumors from integrated genomic profiles by deep neural networks. BMC Med. Genomics 12(1), 143–155 (2019)
Suphavilai, C., Bertrand, D., Nagarajan, N.: Predicting cancer drug response using a recommender system. Bioinformatics 34(22), 3907–3914 (2018)
LeCun, Y., Bengio, Y., Hinton, G.: Deep learning. Nature 521(7553), 436–444 (2015)
Baptista, D., Ferreira, P.G., Rocha, M.: Deep learning for drug response prediction in cancer. Brief. Bioinform. 22(1), 360–379 (2021)
Wainberg, M., Merico, D., Delong, A., et al.: Deep learning in biomedicine. Nat. Biotechnol. 36(9), 829–838 (2018)
Menden, M.P., Iorio, F., Garnett, M., et al.: Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One 8(4), e61318 (2013)
Kim, K.G.: Book review: deep learning. Healthcare Inform. Res. 22(4), 351 (2016)
Kingma, D.P., Welling, M.: Auto-encoding variational bayes. ArXiv Preprint ArXiv 1312, 6114 (2013)
LeCun, Y., Jackel, L.D., Boser, B., et al.: Handwritten digit recognition: applications of neural network chips and automatic learning. IEEE Commun. Mag. 27(11), 41–46 (1989)
Lipton, Z.C., Berkowitz, J., Elkan, C.: A critical review of recurrent neural networks for sequence learning. ArXiv Preprint ArXiv 1506, 00019 (2015)
Lenselink, E.B., TenDijke, N., Bongers, B., et al.: Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set. J. Cheminformatics 9(1), 1–14 (2017)
Koutsoukas, A., Monaghan, K.J., Li, X., et al.: Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data. J. Cheminformatics 9(1), 1–13 (2017)
Ma, J., Sheridan, R.P., Liaw, A., et al.: Deep neural nets as a method for quantitative structure–activity relationships. J. Chem. Inf. Model. 55(2), 263–274 (2015)
Mayr, A., Klambauer, G., Unterthiner, T., et al.: DeepTox: toxicity prediction using deep learning. Front. Environ. Sci. 3, 80 (2016)
Korotcov, A., Tkachenko, V., Russo, D.P., et al.: Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets. Mol. Pharm. 14(12), 4462–4475 (2017)
Eckert, H., Bajorath, J.: Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov. Today 12(5–6), 225–233 (2007)
Iorio, F., Knijnenburg, T.A., Vis, D.J., et al.: A landscape of pharmacogenomic interactions in cancer. Cell 166(3), 740–754 (2016)
Barrett, T., Wilhite, S.E., Ledoux, P., et al.: NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 41(D1), D991–D995 (2012)
Szklarczyk, D., Franceschini, A., Kuhn, M., et al.: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39(suppl_1), D561–D568 (2010)
Szklarczyk, D., Gable, A.L., Lyon, D., et al.: STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607–D613 (2019)
Oughtred, R., Chatr-aryamontri, A., Breitkreutz, B.J., et al.: BioGRID: a resource for studying biological interactions in yeast. Cold Spring Harbor Protocols 2016(1), pdb. top080754 (2016)
Tomczak, K., Czerwińska, P., Wiznerowicz, M.: The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contem. Oncol. 19(1A), A68 (2015)
Kanehisa, M., Furumichi, M., Tanabe, M., et al.: KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45(D1), D353–D361 (2017)
Acknowledgement
This work has been supported by the National Natural Science Foundation of China (Grant No. 61772197).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this paper
Cite this paper
Li, G., Xie, M. (2021). Research on Drug Response Prediction Model Based on Big Data. In: Sun, X., Zhang, X., Xia, Z., Bertino, E. (eds) Advances in Artificial Intelligence and Security. ICAIS 2021. Communications in Computer and Information Science, vol 1422. Springer, Cham. https://doi.org/10.1007/978-3-030-78615-1_46
Download citation
DOI: https://doi.org/10.1007/978-3-030-78615-1_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78614-4
Online ISBN: 978-3-030-78615-1
eBook Packages: Computer ScienceComputer Science (R0)